The Role of Chemical Neurolysis in Cancer Pain
- 523 Downloads
Pain continues to be a significant symptom burden in cancer patients, with prevalence in 53% of patients at all stages of cancer and as high as 58% to 69% in those with advanced cancer. Neurolytic blocks are a mainstay in the armamentarium of cancer pain management, more so in intractable pain from advanced cancer. There is no clear consensus on patient selection, technique, or timing of these blocks. Here we discuss the use of various neurolytic blocks for cancer pain and detail some of the recent literature and our experience.
KeywordsCancer pain Neurolysis
Dr. Allen Burton received research funding from Medtronic, Inc, has served as a consultant for Infusion Systems and Stryker, and served as a speaker for Elan. Dr. Dhanalakshmi Koyyalagunta has received research funding from Medtronic, Inc.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.• Burton AW, Hamid B: Current challenges in cancer pain management: does the WHO ladder approach still have relevance? Expert Rev Anticancer Ther 2007, 7:1501–1502. The rationale is that though the WHO ladder approach to cancer pain management is effective in 71% of those treated, effectiveness was not achieved quickly in one third of the patients. Often times, an interventional treatment concurrent with opioid use may be optimal.CrossRefPubMedGoogle Scholar
- 5.Burton AW, Phan PC, Cousins MJ: Treatment of Cancer Pain: Role of Neural Blockade and Neuromodulation. In Neural Blockade in Clinical Anesthesia and Pain Medicine, edn 4. Edited by Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO. Philadelphia: Lippincott Williams and Wilkins; 2009:1111–1153.Google Scholar
- 14.American Cancer Society: Cancer facts and figures 2009. Atlanta: American Cancer Society; 2009.Google Scholar
- 15.Kappis M: Erfahrungen mit local anasthesie bie bauchoperatonen. Vehr Dtsch Gesellsch Chir 1914:87–89.Google Scholar
- 22.•• Wong GY, Schroeder DR, Carns PE, et al.: Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004, 291:1092–1099. A careful reading of this study reveals significant improvements on many fronts despite a relatively low symptom burden at entry for the block in this study. CrossRefPubMedGoogle Scholar
- 23.Shah H, Burton A: Neurolytic Blockade of the Splanchnic Nerves Block Relieves Refractory Pain Associated with Upper Abdominal Malignancy. Paper presented at the American Society of Anesthesiologists Annual Meeting. San Francisco, CA; October 11–15, 2003.Google Scholar
- 30.Plancarte R, Amescua C, Patt RB: Presacral blockade of the ganglion of Walther (ganglion impar). Anesthesiology 1990, 73(3A):A751Google Scholar
- 33.Dogliotti A: Traitement des syndromes douloureux de la périphérie par l’alcoolisation sub-arachnoidienne des racines postérieures à leur émergence de la moelle épinière Press Med 1931, 29:1249–1252.Google Scholar